Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02357147
Title Study of the Safety and Efficacy of Amatuximab in Combination With Pemetrexed and Cisplatin in Subjects With Unresectable Malignant Pleural Mesothelioma (MPM). (ARTEMIS)
Acronym ARTEMIS
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Morphotek
Indications
Therapies
Age Groups: adult
Covered Countries USA | ITA | GBR | FRA | DEU | AUS


No variant requirements are available.